We found that both CDA activity and mRNA levels were significantly higher in the samples of BC patients than in the samples of controls (median: 11.19 vs. 7.70 U/mg protein for CDA activity, and 1.21 vs. 1.00 for CDA mRNA levels, respectively) (Fig. 1b,c). The gene discussed is CDA; the disease is breast cancer.